Cargando…
Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery
Hyaluronic acid (HA), a main component of the extracellular matrix, is widely utilized to deliver anticancer drugs due to its biocompatibility, biodegradability, non-toxicity, non-immunogenicity and numerous modification sites, such as carboxyl and hydroxyl groups. Moreover, HA serves as a natural l...
Autores principales: | Fu, Chao-Ping, Cai, Xing-Yu, Chen, Si-Lin, Yu, Hong-Wei, Fang, Ying, Feng, Xiao-Chen, Zhang, Li-Ming, Li, Chang-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224391/ https://www.ncbi.nlm.nih.gov/pubmed/37242892 http://dx.doi.org/10.3390/polym15102317 |
Ejemplares similares
-
Hyaluronic Acid-Decorated Laponite(®) Nanocomposites for Targeted Anticancer Drug Delivery
por: Jiang, Tingting, et al.
Publicado: (2019) -
Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs
por: Sabit, Hussein, et al.
Publicado: (2022) -
Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives
por: Serrano-Sevilla, Inés, et al.
Publicado: (2019) -
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
por: Edis, Zehra, et al.
Publicado: (2021) -
Targeting Delivery Nanocarriers for (+)-Terrein to
Enhance Its Anticancer Effects
por: Jiang, Yao-Yao, et al.
Publicado: (2020)